PediFETCh: Fecal Transplant in Paediatric Ulcerative Colitis

McMaster Paediatric FMT Research Collaboration

 *Study recruitment complete

Results of the First Pilot Randomized Controlled Trial of Fecal Microbiota Transplant In Pediatric Ulcerative Colitis: Lessons, Limitations, and Future Prospects. Gastroenterology. Published Ahead of Print. 2021

<https://www.gastrojournal.org/article/S0016-5085(21)00739-3/>


Children with ulcerative colitis have unique bacteria in their intestines that differs from children who are healthy, which may be a contributing factor in IBD.

In the “PediFETCh” study (Pediatric Fecal Microbiota Transplant for Ulcerative Colitis) – the first and only of its kind in Canada – our team is testing whether the transplantation of healthy fecal matter from a donor can improve symptoms in kids with IBD. It’s something that’s already been shown to be effective in adults.

This study will tell us whether fecal transplants can be a viable treatment for kids with ulcerative colitis who can’t manage the disease with their current medications.

Graphic Abstract PediFetch UC Trial.png
Previous
Previous

Prospective registry of predictors of enteral autonomy in paediatric intestinal failure

Next
Next

PediCRaFT: Fecal Transplant in Paediatric Crohn’s Disease